HSP90AB1 and breast cancer: It was revealed that LDNASA 11 labelled endogenous Hsp90 (both α and β isoforms) in breast cancer SKBR3 cells after 3 h with sufficient selectivity even using high concentrations of the reagent (~10 μM) (Fig. 5b, Supplementary Figures 12 and 13).